Long-Term Assets: The sum of all assets classified as non-current.
Jazz Pharmaceuticals PLC (JAZZ) had Long-Term Assets of $7.28B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.07B |
|
$293.10M |
|
$134.10M |
|
$934.80M |
|
$732.30M |
|
$336.60M |
|
$-37.40M |
|
$299.20M |
|
$299.20M |
|
$293.10M |
|
$293.10M |
|
$293.10M |
|
$293.10M |
|
$336.60M |
|
$518.00M |
|
61.90M |
|
66.10M |
|
$4.73 |
|
$4.43 |
|
| Balance Sheet Financials | |
$4.58B |
|
$203.10M |
|
|
Long-Term Assets |
$7.28B |
$11.86B |
|
$2.25B |
|
$4.32B |
|
$5.08B |
|
$7.33B |
|
$4.53B |
|
$-1.48B |
|
$4.53B |
|
62.70M |
|
| Cash Flow Statement Financials | |
$408.20M |
|
$123.10M |
|
$-78.50M |
|
$1.39B |
|
$1.84B |
|
$452.40M |
|
$74.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.04 |
|
-- |
|
-- |
|
0.49 |
|
1.18 |
|
87.45% |
|
31.49% |
|
31.49% |
|
-- |
|
27.99% |
|
27.42% |
|
$388.50M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.31 |
|
1.28 |
|
70.42 |
|
6.47% |
|
-19.85% |
|
2.47% |
|
3.31% |
|
$72.29 |
|
$5.88 |
|
$6.18 |
|